UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 602

Sortiert nach

Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study

Frontiers in endocrinology (Lausanne), 2021-07, Vol.12, p.662865-662865

2021

Volltextzugriff (PDF)

Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor Ligands

Frontiers in endocrinology (Lausanne), 2021-03, Vol.12, p.627711-627711

2021

Volltextzugriff (PDF)

Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic–pituitary–adrenal axes in adults: results from a prospective randomized multicenter study

Pituitary, 2016-06, Vol.19 (3), p.332-341

2016

Volltextzugriff (PDF)

BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDY

Endocrine practice, 2017-08, Vol.23 (8), p.962-970

2017

Volltextzugriff (PDF)

Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study

Frontiers in endocrinology (Lausanne), 2022-04, Vol.13, p.899616-899616

2022

Volltextzugriff (PDF)

Growth hormone replacement in adults: Real-world data from two large studies in US and Europe

Growth hormone & IGF research, 2020-02, Vol.50, p.71-82

2020

Volltextzugriff (PDF)

SUCCESSFUL USE OF RITUXIMAB IN A CASE OF RIEDEL THYROIDITIS RESISTANT TO TREATMENT WITH PREDNISONE AND TAMOXIFEN

AACE clinical case reports, 2019-05, Vol.5 (3), p.e218-e221

2019

Volltextzugriff (PDF)

Reduced CV risk with long-term GH replacement in AGHD: data from two large observational studies

Endocrine Connections, 2023-01, Vol.12 (1), p.1-13

2023

Volltextzugriff (PDF)

Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide

The journal of clinical endocrinology and metabolism, 2020-10, Vol.105 (10), p.e3785-e3797

2020

Volltextzugriff (PDF)

Occult Langerhans Cell Histiocytosis Presenting with Papillary Thyroid Carcinoma, a Thickened Pituitary Stalk and Diabetes Insipidus

Case reports in endocrinology, 2016-01, Vol.2016, p.5191903-3

2016

Volltextzugriff (PDF)

RECURRENT INVASIVE DUCTAL BREAST CARCINOMA PRESENTING AS PRIMARY ADRENAL INSUFFICIENCY WITH ADRENAL CRISIS

AACE clinical case reports, 2020-03, Vol.6 (2), p.e50-e53

2020

Volltextzugriff (PDF)

Pasireotide in an insulin-requiring diabetic acromegalic patient without worsening of hyperglycemia

Endocrinology, diabetes & metabolism case reports, 2017-05, Vol.2017 (1), p.1-7

2017

Volltextzugriff (PDF)

Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults

Pituitary, 2013-06, Vol.16 (2), p.220-230

2013

Volltextzugriff (PDF)

Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial

The journal of clinical endocrinology and metabolism, 2020-04, Vol.105 (4), p.e1358-e1376

2020

Volltextzugriff (PDF)

ACROBAT Edge: Safety and Efficacy of Switching Injected SRLs to Oral Paltusotine in Patients With Acromegaly

The journal of clinical endocrinology and metabolism, 2023-05, Vol.108 (5), p.e148-e159

2023

Volltextzugriff (PDF)

Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations

Clinical diabetes and endocrinology, 2020-10, Vol.6 (1), p.1-18, Article 18

2020

Volltextzugriff (PDF)

Patients with Acromegaly Presenting with Colon Cancer: A Case Series

Case reports in endocrinology, 2016-01, Vol.2016, p.5156295-4

2016

Volltextzugriff (PDF)

Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial

The lancet. Diabetes & endocrinology, 2022-02, Vol.10 (2), p.102-111

2022

Volltextzugriff (PDF)

Long-term treatment with pegvisomant as monotherapy in patients with acromegaly: experience from ACROSTUDY

Endocrine practice, 2015-03, Vol.21 (3), p.264-274

2015

Volltextzugriff (PDF)

An evaluation of the Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ) in adult patients with acromegaly, including correlations with other patient-reported outcome measures: data from two large multicenter international studies

Pituitary, 2020-08, Vol.23 (4), p.347-358

2020

Volltextzugriff (PDF)

TRENDS IN GROWTH HORMONE STIMULATION TESTING AND GROWTH HORMONE DOSING IN ADULT GROWTH HORMONE DEFICIENCY PATIENTS: RESULTS FROM THE ANSWER PROGRAM

Endocrine practice, 2016-04, Vol.22 (4), p.396-405

2016

Volltextzugriff (PDF)

Development of a novel patient-reported measure for acromegaly: the Acro-TSQ

Pituitary, 2019-12, Vol.22 (6), p.581-593

2019

Volltextzugriff (PDF)

Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program

Pituitary, 2021-08, Vol.24 (4), p.611-621

2021

Volltextzugriff (PDF)

Lanreotide extended-release aqueous-gel formulation, injected by patient, partner or healthcare provider in patients with acromegaly in the United States: 1-year data from the SODA registry

Pituitary, 2014-02, Vol.17 (1), p.13-21

2014

Volltextzugriff (PDF)

Screening for comorbid conditions in patients enrolled in the SODA registry: a 2-year observational analysis

Endocrine, 2018-07, Vol.61 (1), p.105-117

2018

Volltextzugriff (PDF)

1 – 25 von 602

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(553)
Mit Volltextzugriff
(524)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study

Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor Ligands

Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic–pituitary–adrenal axes in adults: results from a prospective randomized multicenter study

BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDY

Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study

Growth hormone replacement in adults: Real-world data from two large studies in US and Europe

SUCCESSFUL USE OF RITUXIMAB IN A CASE OF RIEDEL THYROIDITIS RESISTANT TO TREATMENT WITH PREDNISONE AND TAMOXIFEN

Reduced CV risk with long-term GH replacement in AGHD: data from two large observational studies

Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide

Occult Langerhans Cell Histiocytosis Presenting with Papillary Thyroid Carcinoma, a Thickened Pituitary Stalk and Diabetes Insipidus

RECURRENT INVASIVE DUCTAL BREAST CARCINOMA PRESENTING AS PRIMARY ADRENAL INSUFFICIENCY WITH ADRENAL CRISIS

Pasireotide in an insulin-requiring diabetic acromegalic patient without worsening of hyperglycemia

Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults

Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial

ACROBAT Edge: Safety and Efficacy of Switching Injected SRLs to Oral Paltusotine in Patients With Acromegaly

Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations

Patients with Acromegaly Presenting with Colon Cancer: A Case Series

Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial

Long-term treatment with pegvisomant as monotherapy in patients with acromegaly: experience from ACROSTUDY

An evaluation of the Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ) in adult patients with acromegaly, including correlations with other patient-reported outcome measures: data from two large multicenter international studies

TRENDS IN GROWTH HORMONE STIMULATION TESTING AND GROWTH HORMONE DOSING IN ADULT GROWTH HORMONE DEFICIENCY PATIENTS: RESULTS FROM THE ANSWER PROGRAM

Development of a novel patient-reported measure for acromegaly: the Acro-TSQ

Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program

Lanreotide extended-release aqueous-gel formulation, injected by patient, partner or healthcare provider in patients with acromegaly in the United States: 1-year data from the SODA registry

Screening for comorbid conditions in patients enrolled in the SODA registry: a 2-year observational analysis

Suchergebnisse filtern